Current and historical daily PS Ratio for COO (
The Cooper Companies Inc
) from 1990 to Jul 21 2026. The price to sales ratio is calculated by taking the current stock price and dividing it by the trailing twelve-month sales per share. The data is updated every 20 minutes during market hours. The PS ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS ratio is a great valuation tool for evaluating cyclical businesses where the PE ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean. Theoper stock (COO) PS ratio as of Jul 21 2026 is 3.31.
More Details
The Cooper Companies Inc (COO) PS Ratio Chart
The Cooper Companies Inc (COO) PS Ratio Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1250
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Theoper PS Ratio Historical Data | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date | PS Ratio Data | Date | PS Ratio Data | ||||||
| 2026-07-21 | 3.3 | 3.34 | 3.28 | 3.31 | 2026-05-14 | 2.8 | 2.84 | 2.78 | 2.82 |
| 2026-07-20 | 3.3 | 3.35 | 3.3 | 3.34 | 2026-05-13 | 2.8 | 2.81 | 2.76 | 2.78 |
| 2026-07-17 | 3.4 | 3.45 | 3.33 | 3.35 | 2026-05-12 | 2.8 | 2.82 | 2.75 | 2.8 |
| 2026-07-16 | 3.3 | 3.42 | 3.33 | 3.41 | 2026-05-11 | 2.8 | 2.82 | 2.75 | 2.75 |
| 2026-07-15 | 3.2 | 3.34 | 3.2 | 3.29 | 2026-05-08 | 2.9 | 2.87 | 2.78 | 2.8 |
| 2026-07-14 | 3.3 | 3.28 | 3.19 | 3.2 | 2026-05-07 | 2.9 | 2.88 | 2.84 | 2.85 |
| 2026-07-13 | 3.3 | 3.35 | 3.3 | 3.33 | 2026-05-06 | 2.9 | 2.88 | 2.8 | 2.85 |
| 2026-07-10 | 3.3 | 3.33 | 3.29 | 3.3 | 2026-05-05 | 2.9 | 2.89 | 2.83 | 2.86 |
| 2026-07-09 | 3.3 | 3.32 | 3.24 | 3.31 | 2026-05-04 | 2.9 | 2.93 | 2.86 | 2.87 |
| 2026-07-08 | 3.3 | 3.33 | 3.23 | 3.25 | 2026-05-01 | 2.9 | 2.94 | 2.88 | 2.91 |
| 2026-07-07 | 3.4 | 3.47 | 3.35 | 3.35 | 2026-04-30 | 2.9 | 2.96 | 2.86 | 2.94 |
| 2026-07-06 | 3.5 | 3.46 | 3.34 | 3.39 | 2026-04-29 | 2.9 | 2.96 | 2.83 | 2.86 |
| 2026-07-02 | 3.4 | 3.47 | 3.38 | 3.46 | 2026-04-28 | 3.0 | 3.03 | 2.94 | 2.94 |
| 2026-07-01 | 3.4 | 3.43 | 3.35 | 3.36 | 2026-04-27 | 3.1 | 3.13 | 3.08 | 3.08 |
| 2026-06-30 | 3.3 | 3.36 | 3.28 | 3.35 | 2026-04-24 | 3.1 | 3.1 | 3.05 | 3.09 |
| 2026-06-29 | 3.3 | 3.34 | 3.28 | 3.33 | 2026-04-23 | 3.2 | 3.22 | 3.09 | 3.11 |
| 2026-06-26 | 3.2 | 3.37 | 3.23 | 3.31 | 2026-04-22 | 3.2 | 3.26 | 3.2 | 3.21 |
| 2026-06-25 | 3.2 | 3.33 | 3.23 | 3.3 | 2026-04-21 | 3.4 | 3.35 | 3.21 | 3.22 |
| 2026-06-24 | 3.1 | 3.23 | 3.1 | 3.21 | 2026-04-20 | 3.3 | 3.37 | 3.32 | 3.33 |
| 2026-06-23 | 3.1 | 3.11 | 3.06 | 3.09 | 2026-04-17 | 3.4 | 3.42 | 3.35 | 3.36 |
| 2026-06-22 | 3.0 | 3.09 | 3.03 | 3.05 | 2026-04-16 | 3.4 | 3.4 | 3.32 | 3.32 |
| 2026-06-18 | 3.0 | 3.09 | 3.03 | 3.08 | 2026-04-15 | 3.4 | 3.44 | 3.34 | 3.37 |
| 2026-06-17 | 3.1 | 3.14 | 3.03 | 3.04 | 2026-04-14 | 3.4 | 3.48 | 3.41 | 3.43 |
| 2026-06-16 | 3.2 | 3.19 | 3.14 | 3.14 | 2026-04-13 | 3.4 | 3.44 | 3.35 | 3.44 |
| 2026-06-15 | 3.2 | 3.2 | 3.15 | 3.16 | 2026-04-10 | 3.5 | 3.46 | 3.4 | 3.41 |
| 2026-06-12 | 3.2 | 3.18 | 3.1 | 3.17 | 2026-04-09 | 3.4 | 3.44 | 3.36 | 3.42 |
| 2026-06-11 | 3.1 | 3.17 | 3.08 | 3.15 | 2026-04-08 | 3.5 | 3.46 | 3.41 | 3.44 |
| 2026-06-10 | 3.2 | 3.2 | 3.15 | 3.16 | 2026-04-07 | 3.4 | 3.37 | 3.29 | 3.34 |
| 2026-06-09 | 3.1 | 3.22 | 3.09 | 3.2 | 2026-04-06 | 3.4 | 3.39 | 3.34 | 3.37 |
| 2026-06-08 | 3.1 | 3.18 | 3.06 | 3.12 | 2026-04-02 | 3.4 | 3.44 | 3.32 | 3.36 |
| 2026-06-05 | 3.0 | 3.15 | 3.03 | 3.14 | 2026-04-01 | 3.4 | 3.47 | 3.41 | 3.42 |
| 2026-06-04 | 2.9 | 2.94 | 2.85 | 2.89 | 2026-03-31 | 3.4 | 3.44 | 3.33 | 3.43 |
| 2026-06-03 | 2.8 | 2.83 | 2.78 | 2.82 | 2026-03-30 | 3.4 | 3.37 | 3.31 | 3.32 |
| 2026-06-02 | 2.8 | 2.81 | 2.76 | 2.78 | 2026-03-27 | 3.4 | 3.42 | 3.33 | 3.34 |
| 2026-06-01 | 2.8 | 2.84 | 2.77 | 2.81 | 2026-03-26 | 3.4 | 3.48 | 3.41 | 3.43 |
| 2026-05-29 | 2.8 | 2.89 | 2.82 | 2.86 | 2026-03-25 | 3.4 | 3.45 | 3.35 | 3.42 |
| 2026-05-28 | 2.8 | 2.86 | 2.8 | 2.85 | 2026-03-24 | 3.4 | 3.42 | 3.31 | 3.38 |
| 2026-05-27 | 2.9 | 2.91 | 2.83 | 2.84 | 2026-03-23 | 3.4 | 3.45 | 3.35 | 3.37 |
| 2026-05-26 | 2.9 | 2.93 | 2.89 | 2.89 | 2026-03-20 | 3.4 | 3.39 | 3.32 | 3.35 |
| 2026-05-22 | 2.9 | 2.95 | 2.9 | 2.92 | 2026-03-19 | 3.4 | 3.43 | 3.36 | 3.39 |
| 2026-05-21 | 2.9 | 2.95 | 2.83 | 2.93 | 2026-03-18 | 3.4 | 3.46 | 3.4 | 3.41 |
| 2026-05-20 | 2.9 | 2.9 | 2.82 | 2.88 | 2026-03-17 | 3.4 | 3.5 | 3.42 | 3.45 |
| 2026-05-19 | 2.9 | 2.9 | 2.82 | 2.87 | 2026-03-16 | 3.4 | 3.43 | 3.35 | 3.4 |
| 2026-05-18 | 2.8 | 2.86 | 2.78 | 2.84 | 2026-03-13 | 3.4 | 3.45 | 3.35 | 3.35 |
| 2026-05-15 | 2.8 | 2.85 | 2.78 | 2.78 | 2026-03-12 | 3.5 | 3.51 | 3.36 | 3.43 |
The Cooper Companies Inc (COO) PS Ratio Comparison
| Company | Market Cap(Mil) | PS Ratio |
|---|
Business Description
Business Description
The Cooper Companies Inc
NAICS : 339115
SIC : 3851
ISIN : US2166485019
Share Class Description:
COO: Ordinary SharesTotal Employee Number:
15,000Compare
Compare
Traded in other countries / regions
COO.USA0I3I.UKCP60.GermanyCOO.MexicoC1OO34.Brazil1COO.Italy Index Membership
S&P 500Russell 1000Russell 3000MSCI World Index IPO Date
1983-01-21Description
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers